Literature DB >> 24646738

Polymicrobial sepsis alters antigen-dependent and -independent memory CD8 T cell functions.

Sean Duong1, Stephanie A Condotta, Deepa Rai, Matthew D Martin, Thomas S Griffith, Vladimir P Badovinac.   

Abstract

Mortality from sepsis frequently results from secondary infections, and the extent to which sepsis affects pathogen-specific memory CD8 T cell responses remains unknown. Using the cecal ligation and puncture model of polymicrobial sepsis, we observed rapid apoptosis of pre-existing memory CD8 T cells after sepsis induction that led to a loss in CD8 T cell-mediated protection. Ag sensitivity (functional avidity) and Ag-driven secondary expansion of memory CD8 T cells were decreased after sepsis, further contributing to the observed loss in CD8 T cell-mediated immunity. Moreover, Ag-independent bystander activation of memory CD8 T cells in response to heterologous infection was also significantly impaired early after sepsis induction. The reduced sensitivity of pre-existing memory CD8 T cells to sense inflammation and respond to heterologous infection by IFN-γ production was observed in inbred and outbred hosts and controlled by extrinsic (but not cell-intrinsic) factors, suggesting that sepsis-induced changes in the environment regulate innate functions of memory CD8 T cells. Taken together, the data in this study revealed a previously unappreciated role of sepsis in shaping the quantity and functionality of infection- or vaccine-induced memory CD8 T cells and will help further define the decline in T cell-mediated immunity during the sepsis-induced phase of immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24646738      PMCID: PMC4001259          DOI: 10.4049/jimmunol.1303460

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Regulation of innate CD8+ T-cell activation mediated by cytokines.

Authors:  Bailey E Freeman; Erika Hammarlund; Hans-Peter Raué; Mark K Slifka
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  IFN-alpha beta and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions.

Authors:  Heather D Marshall; Amanda L Prince; Leslie J Berg; Raymond M Welsh
Journal:  J Immunol       Date:  2010-06-30       Impact factor: 5.422

3.  IL-7 restores lymphocyte functions in septic patients.

Authors:  Fabienne Venet; Anne-Perrine Foray; Astrid Villars-Méchin; Christophe Malcus; Françoise Poitevin-Later; Alain Lepape; Guillaume Monneret
Journal:  J Immunol       Date:  2012-10-10       Impact factor: 5.422

4.  Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner.

Authors:  Talyn Chu; Aaron J Tyznik; Sarah Roepke; Amy M Berkley; Amanda Woodward-Davis; Laura Pattacini; Michael J Bevan; Dietmar Zehn; Martin Prlic
Journal:  Cell Rep       Date:  2013-03-21       Impact factor: 9.423

Review 5.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

6.  Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection.

Authors:  Stephanie A Condotta; Deepa Rai; Britnie R James; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

7.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

8.  Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study.

Authors:  Mitchell M Levy; Antonio Artigas; Gary S Phillips; Andrew Rhodes; Richard Beale; Tiffany Osborn; Jean-Louis Vincent; Sean Townsend; Stanley Lemeshow; R Phillip Dellinger
Journal:  Lancet Infect Dis       Date:  2012-10-26       Impact factor: 25.071

9.  Pathogen-specific inflammatory milieux tune the antigen sensitivity of CD8(+) T cells by enhancing T cell receptor signaling.

Authors:  Martin J Richer; Jeffrey C Nolz; John T Harty
Journal:  Immunity       Date:  2012-12-20       Impact factor: 31.745

Review 10.  Role of lymphocytic choriomeningitis virus (LCMV) in understanding viral immunology: past, present and future.

Authors:  Xin Zhou; Srividya Ramachandran; Margaret Mann; Daniel L Popkin
Journal:  Viruses       Date:  2012-10-29       Impact factor: 5.048

View more
  38 in total

1.  Cutting Edge: Polymicrobial Sepsis Has the Capacity to Reinvigorate Tumor-Infiltrating CD8 T Cells and Prolong Host Survival.

Authors:  Derek B Danahy; Isaac J Jensen; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2019-04-10       Impact factor: 5.422

2.  Attrition of memory CD8 T cells during sepsis requires LFA-1.

Authors:  Mara A Serbanescu; Kimberly M Ramonell; Annette Hadley; Lindsay M Margoles; Rohit Mittal; John D Lyons; Zhe Liang; Craig M Coopersmith; Mandy L Ford; Kevin W McConnell
Journal:  J Leukoc Biol       Date:  2016-06-10       Impact factor: 4.962

Review 3.  Clinical and Experimental Sepsis Impairs CD8 T-Cell-Mediated Immunity.

Authors:  Derek B Danahy; Robert K Strother; Vladimir P Badovinac; Thomas S Griffith
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

4.  Sepsis-Induced State of Immunoparalysis Is Defined by Diminished CD8 T Cell-Mediated Antitumor Immunity.

Authors:  Derek B Danahy; Samarchith P Kurup; Christina S Winborn; Isaac J Jensen; John T Harty; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2019-06-12       Impact factor: 5.422

Review 5.  Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity.

Authors:  Isaac J Jensen; Frances V Sjaastad; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2018-03-01       Impact factor: 5.422

6.  Polymicrobial Sepsis Diminishes Dendritic Cell Numbers and Function Directly Contributing to Impaired Primary CD8 T Cell Responses In Vivo.

Authors:  Robert K Strother; Derek B Danahy; Dmitri I Kotov; Tamara A Kucaba; Zeb R Zacharias; Thomas S Griffith; Kevin L Legge; Vladimir P Badovinac
Journal:  J Immunol       Date:  2016-10-26       Impact factor: 5.422

Review 7.  Pathophysiology of septic shock: From bench to bedside.

Authors:  Kevin W McConnell; Craig M Coopersmith
Journal:  Presse Med       Date:  2016-04-13       Impact factor: 1.228

8.  Increased attrition of memory T cells during sepsis requires 2B4.

Authors:  Jianfeng Xie; Ching-Wen Chen; Yini Sun; Sonia J Laurie; Wenxiao Zhang; Shunsuke Otani; Gregory S Martin; Craig M Coopersmith; Mandy L Ford
Journal:  JCI Insight       Date:  2019-05-02

Review 9.  New Insights into the Immune System Using Dirty Mice.

Authors:  Sara E Hamilton; Vladimir P Badovinac; Lalit K Beura; Mark Pierson; Stephen C Jameson; David Masopust; Thomas S Griffith
Journal:  J Immunol       Date:  2020-07-01       Impact factor: 5.422

10.  Gut Microbial Membership Modulates CD4 T Cell Reconstitution and Function after Sepsis.

Authors:  Javier Cabrera-Perez; Jeffrey C Babcock; Thamotharampillai Dileepan; Katherine A Murphy; Tamara A Kucaba; Vladimir P Badovinac; Thomas S Griffith
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.